Revisión por temas de las últimas publicaciones en las que han participado miembros del grupo.

Archivado en Noticias

Opciones terapéuticas y EII

  1. Revisando el papel terapéutico de la budesonida en la enfermedad de Crohn. Reviewing the therapeutic role of budesonide in Crohn’s disease
    AntonioLópez-Sanromán, JoanClofent, Esther García-Planella, LuisMenchén, PilarNos, IagoRodríguez-Lago, Eugeni Domènech. https://doi.org/10.1016/j.gastrohep.2018.05.013
  2. Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.
    Panés J, Salas A.
    J Crohns Colitis. 2018 Aug 22;12(suppl_2):S633-S640. doi: 10.1093/ecco-jcc/jjy011. PMID: 30137311
  3. A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells.
    Georgiev-Hristov T, Guadalajara H, Herreros MD, Lightner AL, Dozois EJ, García-Arranz M, García-Olmo D.
    J Gastrointest Surg. 2018 Jul 31. doi: 10.1007/s11605-018-3895-6. [Epub ahead of print] PMID: 30066070 [PubMed – as supplied by publisher]
  4. Risankizumab in patients with moderate to severe Crohn’s disease: an open-label extension study.
    Feagan BG, Panés J, Ferrante M, Kaser A, D’Haens GR, Sandborn WJ, Louis E, Neurath MF, Franchimont D, Dewit O, Seidler U, Kim KJ, Selinger C, Padula SJ, Herichova I, Robinson AM, Wallace K, Zhao J, Minocha M, Othman AA, Soaita A, Visvanathan S, Hall DB, Böcher WO.
    Lancet Gastroenterol Hepatol. 2018 Jul 25. pii: S2468-1253(18)30233-4. doi: 10.1016/S2468-1253(18)30233-4. [Epub ahead of print]. PMID: 30056030 [PubMed – as supplied by publisher]
  5. Adalimumab-induced autoimmune hepatitis in a patient with Crohn’s disease.
    Miranda-Bautista J, Menchén L.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191-2. doi: 10.1016/j.gastrohep.2018.06.006. [Epub ahead of print] English, Spanish. No abstract available. PMID: 30029925 [PubMed – as supplied by publisher]

Prevención, seguridad y profilaxis

  1. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
    de Francisco R, Castaño-García A, Martínez-González S, Pérez-Martínez I, González-Huerta AJ, Morais LR, Fernández-García MS, Jiménez S, Díaz-Coto S, Flórez-Díez P, Suárez A, Riestra S.
    Aliment Pharmacol Ther. 2018 Aug 10. doi: 10.1111/apt.14933. [Epub ahead of print]
  2. Serial Tuberculin Skin Tests Improves the Detection of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.
    Taxonera C, Ponferrada Á, Riestra S, Bermejo F, Saro C, Martín-Arranz MD, Cabriada JL, Barreiro-de Acosta M, de Castro ML, López-Serrano P, Barrio J, Suarez C, Iglesias E, Argüelles-Arias F, Ferrer I, Marín-Jiménez I, Hernández-Camba A, Bastida G, Van Domselaar M, Martínez-Montiel P, Olivares D, Rivero M, Fernandez-Salazar L, Nantes Ó, Merino O, Alba C, Gisbert JP;
    CONVERT study group from GETECCU. J Crohns Colitis 2018 Jul 21. doi: 10.1093/ecco-jcc/jjy104. [Epub ahead of print] PMID: 30052856
  3. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.
    Zammit SC, Ellul P, Girardin G, Valpiani D, Nielsen KR, Olsen J, Goldis A, Lazar D, Shonová O, Nováková M, Sebastian S, Whitehead E, Carmona A, Martinez-Cadilla J, Dahlerup JF, Kievit ALH, Thorsgaard N, Katsanos KH, Christodoulou DK, Magro F, Salupere R, Pedersen N, Kjeldsen J, Carlsen K, Ioannis K, Bergemalm D, Halfvarson J, Duricova D, Bortlik M, Collin P, Oksanen P, Kiudelis G, Kupcinskas L, Kudsk K, Andersen V, O’Morain C, Bailey Y, Doron S, Shmuel O, Almer S, Arebi N, Misra R, Čuković-Čavka S, Brinar M, Munkholm P, Vegh Z, Burisch J.
    Eur J Gastroenterol Hepatol. 2018 Aug 21. doi: 10.1097/MEG.0000000000001238. [Epub ahead of print] PMID: 30134383 [PubMed – as supplied by publisher]
  4. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
    Azuara D, Aussó S, Rodriguez-Moranta F, Guardiola J, Sanjuan X, Lobaton T, Boadas J, Piqueras M, Monfort D, Guinó E, Moreno V, Capellá G, de Oca J.
    Inflamm Bowel Dis. 2018 Aug 7. doi: 10.1093/ibd/izy255. [Epub ahead of print] PMID: 30099509 [PubMed – as supplied by publisher]

Predicción de respuesta y progresión

  1. Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn’s Disease.
    Beltrán B, Iborra M, Sáez-González E, Marqués-Miñana MR, Moret I, Cerrillo E, Tortosa L, Bastida G, Hinojosa J, Poveda-Andrés JL, Nos P.
    Dig Dis. 2018 Aug 27:1-8. doi: 10.1159/000492626. [Epub ahead of print] PMID: 30149385 [PubMed – as supplied by publisher]
  2. Characteristics and Progression of Preclinical Inflammatory Bowel Disease.
    Rodríguez-Lago I, Merino O, Azagra I, Maiz A, Zapata E, Higuera R, Montalvo I, Fernández-Calderón M, Arreba P, Carrascosa J, Iriarte A, Portillo I, Aguirre U, Barreiro-de Acosta M, Muñoz-Navas M, Cabriada JL.
    Clin Gastroenterol Hepatol. 2018 Sep;16(9):1459-1466. doi: 10.1016/j.cgh.2017.11.006. Epub 2017 Nov 11.
    PMID: 29133254 [PubMed – in process]

 

Guías ECCO-ESGAR

  1. ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.
    Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustinš E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, González Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J;
    European Crohn’s and Colitis Organisation [ECCO]; European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. J Crohns Colitis. 2018 Aug 23. doi: 10.1093/ecco-jcc/jjy114. [Epub ahead of print] No abstract available. PMID: 30137278 [PubMed – as supplied by publisher]
  2. ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.
    Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J; European Crohn’s and Colitis Organisation [ECCO]; European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. J Crohns Colitis. 2018 Aug 23. doi: 10.1093/ecco-jcc/jjy113. [Epub ahead of print] No abstract available. PMID: 30137275 [PubMed – as supplied by publisher]

Pediatría

  1. Endoscopy in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto IBD Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition.
    Oliva S, Thomson M, de Ridder L, Martín-de-Carpi J, Van Biervliet S, Braegger C, Dias JA, Kolacek S, Miele E, Buderus S, Bronsky J, Winter H, Navas-López VM, Assa A, Chong SKF, Afzal NA, Smets F, Shaoul R, Hussey S, Turner D, Cucchiara S
    J Pediatr Gastroenterol Nutr. 2018 Sep;67(3):414-430. doi: 10.1097/MPG.0000000000002092. PMID: 30130311 [PubMed – in process]
  2. Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.
    Joosse ME, Aardoom MA, Kemos P, Turner D, Wilson DC, Koletzko S, Martin-de-Carpi J, Fagerberg UL, Spray C, Tzivinikos C, Sladek M, Shaoul R, Roma-Giannikou E, Bronsky J, Serban DE, Ruemmele FM, Garnier-Lengline H, Veres G, Hojsak I, Kolho KL, Davies IH, Aloi M, Lionetti P, Hussey S, Veereman G, Braegger CP, Trindade E, Wewer AV, Hauer AC, de Vries ACH, Sigall Boneh R, Sarbagili Shabat C, Levine A, de Ridder L; Paediatric IBD Porto group of ESPGHAN.
    Aliment Pharmacol Ther. 2018 Sep;48(5):523-537. doi: 10.1111/apt.14893. Epub 2018 Jul 8. PMID: 29984520 [PubMed – in process]
  3. Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease.
    Lawley M, Wu JW, Navas-López VM, Huynh HQ, Carroll MW, Chen M, Medvedev P, Day AS, Hussey S, Sigall-Boneh R, Levine A, Wine E.
    J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):e22-e29. doi: 10.1097/MPG.0000000000001946. PMID: 29543696 [PubMed – in process]
  4. Magnetic Resonance Enterography Cannot Replace Upper Endoscopy in Pediatric Crohn Disease: An Imagekids Sub-study.
    Church PC, Kuint RC, Ledder O, Navas-López VM, Sladek M, Brückner A, Baldassano RN, Weiss B, Yerushalmi B, Saeed SA, Hyams J, Otley A, Griffiths AM, Turner D, Greer MC; ImageKids Study group.
    J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):53-58. doi: 10.1097/MPG.0000000000001869.
    PMID: 29287012 [PubMed – in process]

 

archivado en Noticias | publicado el 4 de septiembre de 2018 | última actualización: 4 de septiembre de 2018 16:51
Formación EII
Canal de GETECCU en YouTube
Base de datos ENEIDA
Nuestros patrocinadores|lea nuestra política de patrocinio